AU2002349934A1 - Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract - Google Patents

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Info

Publication number
AU2002349934A1
AU2002349934A1 AU2002349934A AU2002349934A AU2002349934A1 AU 2002349934 A1 AU2002349934 A1 AU 2002349934A1 AU 2002349934 A AU2002349934 A AU 2002349934A AU 2002349934 A AU2002349934 A AU 2002349934A AU 2002349934 A1 AU2002349934 A1 AU 2002349934A1
Authority
AU
Australia
Prior art keywords
dosage form
gastrointestinal tract
oral dosage
drug release
lower gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349934A
Inventor
Bret Berner
Jenny Louie-Helm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assertio Therapeutics Inc
Original Assignee
Depomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depomed Inc filed Critical Depomed Inc
Publication of AU2002349934A1 publication Critical patent/AU2002349934A1/en
Abandoned legal-status Critical Current

Links

AU2002349934A 2001-10-25 2002-10-25 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract Abandoned AU2002349934A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/045,816 2001-10-25
US10/024,932 2001-12-18

Publications (1)

Publication Number Publication Date
AU2002349934A1 true AU2002349934A1 (en) 2003-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP1594477A4 (en) Active drug delivery in the gastrointestinal tract
EP1556010A4 (en) Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
AU2002363998A8 (en) Bioadhesive drug delivery system with enhanced gastric retention
AU2002301259A1 (en) Simethicone solid oral dosage form
IL160117A0 (en) Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
ZA200207755B (en) Simethicone solid oral dosage form.
AU6089200A (en) Rapid immediate release oral dosage form
IL162671A0 (en) Micronized pharmaceutical or nutraceutical powder with immediate release
ZA200501084B (en) Dispersible tablets for oral administration
GB0117618D0 (en) Pharmaceutical dosage form
AU3574500A (en) Rapidly disintegrable tablet for oral administration
PL364621A1 (en) Nicotine-containing oral dosage form
GB0117619D0 (en) Pharmaceutical dosage form
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
GB2383989B (en) Improved oral medicine dispenser
EP1207852A4 (en) Controlled release oral dosage suitable for oral administration
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
HK1072194A1 (en) Oral dosage form for controlled drug release
AU2002251448A1 (en) Oral absorbed drugs
IL162510A0 (en) Pharmaceutical suspension for oral administration
HUP0401599A3 (en) Extended release oral dosage form
AU2002349934A1 (en) Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1357898A4 (en) Improved controlled release oral dosage form
HK1054695A1 (en) Oral administration preparation improved in absorbability